23F-17337-22173
3 vaccinations
12 coded responses
33 check-ins
12 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 228 / VA
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Dose 1 — Pfizer-BioNTech
-
2021-01-23
Registered in v-safe
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-02-01
-
2021-02-08
Dose 2 — Pfizer-BioNTech
- 2021-02-08
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased, Feeling abnormal, Fluid retention, Weight increased — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Foggy-headed; fluid retention up 4lbs; not diabetic or prediabetic but fasting blood sugar is elevated to 135MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Foggy-headedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal, Fluid retention — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to workFree text: Foggy headed, fluid retentionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — days 1–6 daily, dose 2MedDRA: Muscular weakness, Paraesthesia — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Muscle weakness, paresthesia bottom of both feet, muscle weaknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
-
2021-03-15
Survey response — day 35, dose 2MedDRA: Fatigue, Headache — Feeling: FairFree text: FatigueHeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
-
2021-05-10
Survey response — 3 months, dose 2MedDRA: Depression — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: DepressionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-10
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-09
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Fatigue or tirednessAdult check-in
- 2021-10-03
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · FeverFree text: Slightly swollen and painful lymph nodes near clavicle on same side of body as booster shotMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain — Feeling: Good · Site: PainFree text: Painful lymph glandsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — day 7, dose 3MedDRA: Lymph node pain — Feeling: GoodFree text: Lymph nodes remain soreMedDRA releases: 2024-11 · check-in free text available
- 2021-10-13
- 2021-10-20
-
2021-10-27
Survey response — day 28, dose 3MedDRA: Abdominal pain, Body temperature increased, Diarrhoea, Malaise, Nausea, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Nausea, vomiting, fever 99.9, malaise, abd pain, loose stoolMedDRA releases: 2024-11 · check-in free text available
- 2021-11-03
-
2021-11-10
Survey response — day 42, dose 3MedDRA: Headache — Feeling: FairFree text: Days long headacheMedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Fatigue, Lymph node pain, Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend schoolFree text: Sore throat, swollen and painful cervical lymph nodes, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-03-30
-
2022-04-18
Call successfulNot applicable - Accidental Reporting
- 2022-09-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech | |
| 2 | 2021-02-08 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Foggy-headed; fluid retention up 4lbs; not diabetic or prediabetic but fasting blood sugar is elevated to 135
Systemic reaction (other): Foggy-headed
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Foggy headed, fluid retention
Systemic reaction (other): Muscle weakness, paresthesia bottom of both feet, muscle weakness
Release 5 — day 35, dose 2
Symptoms: FatigueHeadache
Release 8 — 3 months, dose 2
Symptoms: Depression
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Slightly swollen and painful lymph nodes near clavicle on same side of body as booster shot
Systemic reaction (other): Painful lymph glands
Release 10 — day 7, dose 3
Systemic reaction (other): Lymph nodes remain sore
Release 10 — day 28, dose 3
Symptoms: Nausea, vomiting, fever 99.9, malaise, abd pain, loose stool
Release 10 — day 42, dose 3
Symptoms: Days long headache
Release 10 — 3 months, dose 3
Symptoms: Sore throat, swollen and painful cervical lymph nodes, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Depression | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lymph node pain | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Blood glucose increased | · | · | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Fluid retention | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Weight increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release